InsidersTradesSigma
신테카바이오: directors' dealings · South Korea · DART (FSS)
DART:company-877e4fKR·DART (FSS)Mcap 42.3Bn€Healthcare
Explore the full insider trade history of 신테카바이오, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 신테카바이오 has published 2 public disclosures. Market capitalisation: €42.3bn. The latest transaction was filed on 7 April 2026 — Purchase. Among the most active insiders: 조영국. The full history is openly available.
2
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2320.00 €
Analyst consensus
Income statement
Revenue3.43 Bn€
Gross profit3.43 Bn€100% margin
Net income−17.38 Bn€-506.8% margin
Valuation
PER (forward)-16.9x
Beta0.52
Balance sheet & cash
Market cap42.35 Bn€
Total debt7.13 Bn€
Free Cash Flow−10.73 Bn€
Debt / Equity22%
Profitability & ownership
ROE-61.3%
ROA-14.9%
% insiders15.1%
% institutions0.1%
Last declaration on 7 April 2026
Declarations0 total
No declarations found
0 of 0 declarations